MEDIUM confidence: 100% data completeness, but the composite (60) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 3.0%/yr (revenue basis).
Base free cash flow $2.4B (avg FY2023–FY2025; latest year $1.4B) · equity value $93.5B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Avg target $185 (last qtr, 5 analysts) → $184 (last mo, 4) (-0.7%).
Buy-rated share 47% → 50% over ~3 months (+3pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $2.25 | $2.40 | +6.7% |
| Apr 2026 | $1.98 | $2.14 | +8.1% |
| Jan 2026 | $1.80 | $1.83 | +1.7% |
| Oct 2025 | $2.07 | $2.19 | +5.8% |
| Jul 2025 | $2.01 | $2.16 | +7.5% |
| Apr 2025 | $1.78 | $1.88 | +5.6% |
| Jan 2025 | $1.67 | $1.68 | +0.6% |
| Oct 2024 | $1.91 | $1.98 | +3.7% |
Net insider -$4.3M over 180 days (0 open-market buys, 5 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $35.4B— | $34.2B-3.2% | $24.6B-28.1% | $24.6B-0.1% | $24.9B+1.5% |
| EPS (dil.) | $10.12— | $10.18+0.6% | $-12.63-224.1% | $7.55n/m | $6.00-20.5% |
| Free Cash Flow | $5.9B— | $3.8B-34.3% | $5.1B+31.8% | $638M-87.4% | $1.4B+118.8% |
| Gross Margin | 47.0% | 43.7%-3.3pp | 38.9%-4.8pp | 41.0%+2.1pp | 39.6%-1.5pp |
| Operating Margin | 21.3% | 11.9%-9.4pp | 16.4%+4.5pp | 20.1%+3.6pp | 18.3%-1.8pp |
| Net Margin | 16.7% | 16.9%+0.1pp | -28.4%-45.3pp | 17.0%+45.4pp | 13.0%-4.0pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
The QScore of 60 indicates a moderately attractive stock, driven by strong momentum and profitability scores of 64 and 65, respectively, with the company exhibiting strong momentum and a high ROE of 77.1%. However, the value score of 41 is a drag, as the stock trades at a premium with a P/E of 32.0 and P/B of 32.2. The short-term score is slightly higher than the long-term score, at 62 versus 57, suggesting recent performance has been more favorable.